Human Genome Sciences Stock
Equities
US4449031081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2012 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
2012 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
1st Jan change | Capi. | |
---|---|---|
+33.69% | 49.46B | |
+1.63% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.25% | 26.61B | |
-21.12% | 18.64B | |
+7.41% | 13.16B | |
+28.94% | 12.55B | |
+23.52% | 12.1B |
- Stock Market
- Equities
- Stock